(Q27668184)
Statements
Use of structure-based design to discover a potent, selective, in vivo active phosphodiesterase 10A inhibitor lead series for the treatment of schizophrenia (English)
Christopher J Helal
Zhijun Kang
Xinjun Hou
Thomas A Chappie
John M Humphrey
Eric S Marr
Kimberly F Fennell
Lois K Chenard
Carol Fox
Christopher J Schmidt
Robert D Williams
Douglas S Chapin
Lorraine Lebel
Julia Cianfrogna
Kari R Fonseca
Frederick R Nelson
Rebecca O'Connor
Mary MacDougall
Laura McDowell